iBIO Announces Expansion of Board of Directors, Re-election of Norbert Riedel as...

iBIO Announces Expansion of Board of Directors, Re-election of Norbert Riedel as Chairman

New Members Provide Diverse Expertise
CHICAGO--(Business Wire)--The Illinois Biotechnology Industry Organization (iBIO) today
announced the election of two new members to iBIO's board of
directors, and the re-election of its chairman of the board. New to
iBIO's board of directors are Peter Boynton of Tate & Lyle and Terry
Noetzel of Deloitte Consulting. iBIO's board also re-elected eight
members, including Norbert Riedel, Ph.D., of Baxter International
Inc., who will continue to serve as chairman of the iBIO board.

"We are delighted to welcome Terry and Peter to our board of
directors," said iBIO President and CEO David Miller. "Their diverse
skill sets, representing the service, agricultural and industrial
sectors, will help us continue to grow the biotechnology community in
Illinois and the Midwest. We also are thrilled that Dr. Riedel has
agreed to continue his position as chairman. The iBIO board recognized
that by electing Norbert and his fellow board members to serve an
additional term, our community will benefit from their experience and
outstanding leadership."

Peter (Pete) Boynton is Senior Vice President, Industrial
Ingredients at Tate & Lyle. He brings more than 26 years experience in
the corn wet milling industry. His current responsibilities include
directing the Industrial Ingredients business and leading a
biomaterials business development initiative. Pete's initial
responsibilities with Tate & Lyle included managing their global
citric acid operations. Before joining Tate & Lyle in October 1998, he
had held various management positions with Cargill, Inc., lastly as a
Vice President in the North American Corn Milling group.

Terry Noetzel is global lead client service partner and principal
with Deloitte Consulting LLP. Terry leads Deloitte's Midwest Life
Sciences practice, encompassing Consulting, Tax, Enterprise Risk
Services and Financial Advisory Services. He has more than 25 years
experience in the life sciences and health care industry, with a
particular focus on the health care supply chain. He has led
Deloitte's Chicago-based life sciences & health care management
consulting practice, its health care supply chain practice, and served
as co-leader of Deloitte's global business-to-business practice. Terry
has been with Deloitte since 1985. He previously served in operations
management and strategy roles for the Henry Ford Health System.

Dr. Norbert Riedel is Corporate Vice President and Chief
Scientific Officer at Baxter International Inc. Dr. Riedel has served
on iBIO's Board of Directors since March 2001, and he was named
Chairman of the Board in July 2006. Dr. Riedel has served as Baxter's
Chief Scientific Officer since March 2001. He joined Baxter in 1998 as
President of the recombinant unit within Baxter's BioScience business.
Prior to joining Baxter, Dr. Riedel was head of worldwide
biotechnology and worldwide core research functions at Hoechst Marion
Roussel, now Sanofi-Aventis. He serves as an Adjunct Professor of
Medicine at Northwestern University's Feinberg School of Medicine, and
is a member of the Advisory Board of Northwestern University's Kellogg
School of Management Center for Biotechnology.

The iBIO Board of Directors also re-elected the following members:
Michael Hogg, Business Counsel; Andrew Hull, Takeda Pharmaceuticals
North America; Susan Jones, Ernst & Young; John Larson, Abbott;
Michael Rosen, Forest City Enterprises; Vijaya Vasista, Vasista
Consulting; and Gregory Webb, Archer Daniels Midland Company.

For a complete list of iBIO's Board of Directors, visit
www.ibio.org/about/leadership.html

About iBIO

The Illinois Biotechnology Industry Organization (iBIO) champions
biotechnology in Illinois and the surrounding Midwest region.
Headquartered in Chicago, iBIO's mission is to strengthen the
leadership position of Illinois and the Midwest as a globally
recognized center of medical, agricultural, industrial and
environmental applications of biotechnology. With leaders from
business, academia, and government, iBIO promotes the development and
retention of new companies as well as corporate expansions. We also
advocate sensible public policy at the local, state, and federal
levels. To learn more about iBIO and its programs, visit www.ibio.org.

iBIO's Leadership Sponsors are Abbott, Astellas Pharma US, Baxter
International Inc., Takeda Pharmaceuticals North America, and TAP
Pharmaceutical Products.

Upcoming iBIO and Affiliated Events

SBIR/STTR Workshop

January 28 - 29, 2008 Bell, Boyd & Lloyd LLP Chicago

This two-day intensive workshop will cover all aspects of writing
SBIR/STTR grants focused on life science technologies. The workshop
will cover many agencies, including DoD, NSF and NIH.

2008 iBIO Industry Expo & Marketplace (iBIO IndEx)

February 20, 2008 Hyatt Regency Chicago

The daylong iBIO IndEx is the premier event for the life sciences
in the Midwest. This year's theme, Innovation to Commercialization,
showcases all that Illinois and the region have to offer.

2008 Midwest Venture Summit

March 17, 2008 - March 18, 2008 Chicago, IL

The Midwest Venture Summit is the only Midwest capital conference
presented by Venture Capital firms. These VCs are seeking new
investment opportunities and created a venue where companies at
different stages of development can present their plans. This is the
place to network with the most active VCs, attorneys and accountants
that specialize in early stage companies and entrepreneurs.

Fifth Annual World Congress on Industrial Biotechnology and
Bioprocessing

April 27 - 30, 2008 Chicago Hilton & Towers

The Fifth Annual World Congress on Industrial Biotechnology and
Bioprocessing will provide a forum for interdisciplinary interaction
and networking. The conference program features sessions on a diverse
set of topics involving Industrial Biotechnology & Bioprocessing.

2008 BIO International Convention

June 17, 2008 - June 20, 2008 San Diego, CA

The global event for biotechnology is a blend of international and
domestic executives and management from research, business, academic
and investment communities.

iBIO
Nathan Carris
312.422.1111
ncarris@ibio.org
or
White Oak Communications, Inc.
Jed Weiner
847.392.4186
jed.weiner@comcast.net

Copyright Business Wire 2008